The Effects of Continued Azacitidine (AZA) Treatment Cycles on Response in Higher-Risk Patients (Pts) with Myelodysplastic Syndromes (MDS) / Lewis R. Silverman, Pierre Fenaux, Ghulam J Mufti, Valeria Santini, Eva Hellström-Lindberg, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F Seymour, Jay Backstrom, David McKenzie, and C. L. Beach. - In: BLOOD. - ISSN 0006-4971. - STAMPA. - 112:(2008), pp. 227-227. (ASH san francisco 6-9 dicembre 2008).
The Effects of Continued Azacitidine (AZA) Treatment Cycles on Response in Higher-Risk Patients (Pts) with Myelodysplastic Syndromes (MDS)
SANTINI, VALERIA;
2008
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
